Ecovyst (ECVT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on May 8, 2025, with voting on director elections, executive compensation, and auditor ratification.
Stockholders as of March 24, 2025, are eligible to vote, with 117,385,510 shares outstanding.
The company emphasizes strong governance, board refreshment, and adherence to best practices, including board declassification and robust risk oversight.
Voting matters and shareholder proposals
Stockholders will vote to elect two director nominees as Class III directors for a one-year term.
An advisory vote on executive compensation (say-on-pay) and ratification of PricewaterhouseCoopers LLP as independent auditor for 2025 are on the agenda.
Stockholders may submit proposals for the 2026 annual meeting by December 9, 2025.
Board of directors and corporate governance
The board is transitioning from a classified structure to annual elections, completing declassification by 2027.
Seven of eight directors are independent; half the board is diverse by gender or ethnicity.
Board committees (Audit, Compensation, Nominating and Corporate Governance, Health, Safety, Environment and Security) are fully independent.
Directors are subject to stock ownership guidelines and retirement/tenure policies.
Latest events from Ecovyst
- Strong 2025 growth, major divestiture, debt reduction, and robust 2026 outlook.ECVT
Q4 202526 Feb 2026 - Q2 2024 net income dropped 68% and guidance was lowered as catalyst demand softened.ECVT
Q2 20242 Feb 2026 - Strong demand, catalyst innovation, and sustainability drive growth and investment focus.ECVT
CL King's 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales up 3.4% to $179.2M, with resilient Ecoservices and steady full-year guidance.ECVT
Q3 202417 Jan 2026 - Q3 2024 saw robust cash flow, margin expansion, and a strategic focus on sustainability.ECVT
Bank of America Securities 2024 Leveraged Finance Conference12 Jan 2026 - Q4 growth in core segments, 2025 sales and EBITDA to rise despite Zeolyst JV impairment.ECVT
Q4 202423 Dec 2025 - $556M deal boosts catalyst capabilities, recurring revenue, and global reach.ECVT
M&A Announcement16 Dec 2025 - Q1 2025 sales up 1.1%, EBITDA down 14.5%, net loss $3.6M, guidance raised, key acquisition set.ECVT
Q1 202528 Nov 2025 - Sales up 9.5%, net income down 27.7%, with asset acquisition and buybacks completed.ECVT
Q2 202523 Nov 2025